Sodium Valproate levels in plasma have been measured in 207 children with epilepsy, only 21 of whom were in-patients. No significant correlation could be found between plasma levels and dose of Sodium Valproate expressed as mg/day, mg/kg body weight or mg/m2 surface area. This finding could not be attributed to irregular compliance, concomitant administration of other anticonvulsant drugs, time of sampling after last dose, duration of treatment or age of the child. We could find no evidence of a therapeutic range of plasma levels of Sodium Valproate and the ranges associated with poor (17%), moderate (44%) or good control (39%) of fits were not significantly different. The average daily dose producing an improvement in seizure control was calculated to be 30 mg/kg.
JeavonsPMClarkJE. Sodium Valproate in the treatment of epilepsy. Br Med J1974;584–586.
2.
BruniJWilderBJ. Valproic acid: Review of a new antiepileptic drug. Arch Neurol1979; 36:393–398.
3.
LoiseauPBrachetAHenryP. Concentration of di-propylacetate in plasma. Epilepsia1975; 16:609–615.
4.
SchobbenFvan der KleinEGabreelsFJM. Pharmacokinetics of di-n-propylacetate in epileptic patients. Eur J Clin Pharmacol1975; 8:97–105.
5.
BruniJWilderBJWilmoreLJPerchalskiRJVillarrealHJ. Kinetics of steady state valproic acid in epileptic patients. Clin Pharmacol Ther1978; 24:324–332.
6.
SimonDPenryJK. Sodium di-n-propylacetate (DPA) in the treatment of epilepsy. A review. Epilepsia1975; 16:549–573.
7.
RedenbaughJESatoSPenryJKDreifussFEKupferbergHJ. Sodium Valproate: Pharmacokinetics and effectiveness in treating intractable seizures. Neurology1980; 30:1–6.
8.
MeijerJWAHessing-BrandL. Determination of lower fatty acids, particularly of the antiepileptic dipropylacetic acid, in biological materials by means of microdiffusion and gas chromatography. Clin Chim Acta1973; 43;215–222.
SchobbenFvan der KleinE. Determination of sodium di-n-propylacetate in plasma by gas-liquid chromatography. Pharm Weekbl1974; 109; 30–33.
11.
RichensAScoulerITAhmadSJordanBJ. Pharmacokinetics and efficacy of Epilim in patients receiving long-term therapy with other antiepileptic drugs. In Legg, Ed. Clinical and pharmacological aspects of Sodium Valproate (Epilim) in the treatment of epilepsy. (MCS Consultants,. Tunbridge Wells). 1976: 78–88.
12.
ChadCR. A simple method for the determination of Epilim in serum. In Legg, Ed. Clinical and pharmacological aspects of Sodium Valproate (Epilim) in the treatment of epilepsy. (MCS Consultants, Tunbridge Wells). 1976: 89–91.
13.
VajdaFMorrisPMorrisPDrummerOBladinP. Studies on Sodium Valproate–a new anticonvulsant. In Legg, Ed. Clinical and pharmacological aspects of Sodium Valproate (Epilim) in the treatment of epilepsy. (MCS consultants, Tunbridge Wells). 1976: 92–100.
14.
EspirMLEBentonPWillEHayesMJWalkerG. Sodium Valproate (Epilim)–some clinical and pharmacological aspects. In Legg Ed. Clinical and Pharmacological aspects of Sodium Valproate (Epilim) in the treatment of epilepsy (MCS Consultants, Tunbridge Wells) 1976;145–151.
15.
GrantRHEBarotMH. The use of Sodium Valproate (Epilim) in severely handicapped patients with epilepsy. In Legg Ed. Clinical and Pharmacological aspects of Sodium Valproate (Epilim) in the treatment of epilepsy (MCS Consultants, Tunbridge Wells) 1976;14–21.
16.
GramLFlachasHWurtz-JorgensenAParnasJAndersonB. Sodium Valproate, serum level and clinical effect in epilepsy: A controlled study. Epilepsia1979; 20:303–312.
17.
BarnesSEBowerBD. Sodium Valproate in the treatment of intractable childhood epilepsy. Develop Med Child Neurol1975; 17:175–181.
18.
HaigDForsytheWI. The treatment of childhood epilepsy with Sodium Valproate. Dev Med & Child Neurol1975; 17:743–748.
19.
JeavonsPMClarkJEMaheshwariMC. Treatment of generalised epilepsies of childhood and adolescence with Sodium Valproate ‘Epilim’. Devel Med & Child Neurol1977; 19:9–25.
20.
WulffKFlachsHWurtz-JorgensenAGramL. Clinical pharmacological aspects of Valproate Sodium. Epilepsia1977; 18:149–158.
21.
BriantRHFooteSEWallisWE. Sodium Valproate (Epilim) in epilepsy. A trial. NZ Med J1978; 88:479–482.
22.
ShakirRANandaRNLambieDGJohnstoneRH. Comparative trial of Valproate Sodium and Clonazepam in chronic epilepsy. Arch Neurol1979; 36:301–304.
23.
HassanMNLaljeeHCKParsonageMJ. Sodium Valproate in the treatment of resistant epilepsy. Acta Neurol Scand1976, 54: 209–218.
24.
VajdaFJEDrummerOHMorrisPMMcNeilJJBladinPF. Gas chromatographic measurement of plasma levels of Sodium Valproate; tentative therapeutic range of a new anticonvulsant in the treatment of refractory epileptics. Clin Exp Pharmacol Physiol1978; 5:67–73.
25.
KupferbergJG Nutt. Linear relationships between plasma concentration and dosage of Sodium Valproate. Epilepsia1979; 20:589–592.
26.
LoscherW. Rapid determination of Valproate Sodium in serum by gas-liquid chromatography. Epilepsia1977; 18:225–227.
27.
MeijerJWAMeinardiH. Pharmacokinetic studies on Sodium Valproate. Proceedings of a Symposium at Nottingham University. Ed LeggN. J.1975.
